IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER

Chemotherapy-Related Leukemia

M.D. Anderson Cancer Centermonoclonal_antibodyPhase 2Active

57/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 42/ 100
Competitive Position: 95/ 100

Competitive context

9 Active assets in the Chemotherapy-Related Leukemia cohort.

Asset / Sponsor	Phase	Rating
Fludarabine National Cancer Institute (NCI)	Phase 2	B
Evomela M.D. Anderson Cancer Center	Phase 2	B
TACROLIMUS M.D. Anderson Cancer Center	Phase 2	B
Cyclophosphamide M.D. Anderson Cancer Center	Phase 2	B
Nivolumab M.D. Anderson Cancer Center	Phase 2	B

View all 14 →

Same molecule, other indications

IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:

Recurrent Adult Burkitt LymphomaDormant

BBB

Indicative ·

78 / 100

View asset →

Recurrent Adult Diffuse Small Cleaved Cell LymphomaDormant

BBB

Indicative ·

76 / 100

View asset →

lymphoblastic lymphomaDormant

BBB